nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0829	0.0991	CbGbCtD
Nicardipine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0712	0.0851	CbGbCtD
Nicardipine—CYP2C19—Prednisone—ankylosing spondylitis	0.0534	0.0639	CbGbCtD
Nicardipine—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0532	0.0636	CbGbCtD
Nicardipine—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0525	0.0628	CbGbCtD
Nicardipine—ABCB1—Betamethasone—ankylosing spondylitis	0.0463	0.0553	CbGbCtD
Nicardipine—ABCB1—Prednisolone—ankylosing spondylitis	0.0456	0.0546	CbGbCtD
Nicardipine—ABCB1—Prednisone—ankylosing spondylitis	0.0431	0.0515	CbGbCtD
Nicardipine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0426	0.051	CbGbCtD
Nicardipine—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0413	0.0494	CbGbCtD
Nicardipine—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0398	0.0475	CbGbCtD
Nicardipine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0334	0.0399	CbGbCtD
Nicardipine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0323	0.0386	CbGbCtD
Nicardipine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0277	0.0332	CbGbCtD
Nicardipine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0277	0.0331	CbGbCtD
Nicardipine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0273	0.0327	CbGbCtD
Nicardipine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0269	0.0322	CbGbCtD
Nicardipine—CYP3A4—Prednisone—ankylosing spondylitis	0.0258	0.0309	CbGbCtD
Nicardipine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0254	0.0303	CbGbCtD
Nicardipine—ABCB1—Methotrexate—ankylosing spondylitis	0.0216	0.0259	CbGbCtD
Nicardipine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0161	0.0193	CbGbCtD
Nicardipine—Face oedema—Prednisone—ankylosing spondylitis	0.000636	0.00609	CcSEcCtD
Nicardipine—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.000633	0.00606	CcSEcCtD
Nicardipine—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.000632	0.00605	CcSEcCtD
Nicardipine—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.00063	0.00603	CcSEcCtD
Nicardipine—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.000628	0.00601	CcSEcCtD
Nicardipine—Polyuria—Methotrexate—ankylosing spondylitis	0.000627	0.006	CcSEcCtD
Nicardipine—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.000625	0.00598	CcSEcCtD
Nicardipine—Sweating—Methylprednisolone—ankylosing spondylitis	0.000615	0.00588	CcSEcCtD
Nicardipine—Visual impairment—Prednisolone—ankylosing spondylitis	0.000604	0.00578	CcSEcCtD
Nicardipine—Hypokalaemia—Prednisone—ankylosing spondylitis	0.0006	0.00574	CcSEcCtD
Nicardipine—Rhinitis—Triamcinolone—ankylosing spondylitis	0.000578	0.00553	CcSEcCtD
Nicardipine—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.000577	0.00552	CcSEcCtD
Nicardipine—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.000575	0.0055	CcSEcCtD
Nicardipine—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.000575	0.0055	CcSEcCtD
Nicardipine—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000572	0.00547	CcSEcCtD
Nicardipine—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000572	0.00547	CcSEcCtD
Nicardipine—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.000567	0.00542	CcSEcCtD
Nicardipine—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.000567	0.00542	CcSEcCtD
Nicardipine—Sweating increased—Prednisone—ankylosing spondylitis	0.000555	0.00531	CcSEcCtD
Nicardipine—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000555	0.00531	CcSEcCtD
Nicardipine—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.000524	0.00502	CcSEcCtD
Nicardipine—Vision blurred—Prednisolone—ankylosing spondylitis	0.000515	0.00492	CcSEcCtD
Nicardipine—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000507	0.00485	CcSEcCtD
Nicardipine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000504	0.00483	CcSEcCtD
Nicardipine—Visual impairment—Betamethasone—ankylosing spondylitis	0.000504	0.00483	CcSEcCtD
Nicardipine—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000501	0.00479	CcSEcCtD
Nicardipine—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000498	0.00476	CcSEcCtD
Nicardipine—Malaise—Prednisolone—ankylosing spondylitis	0.000492	0.00471	CcSEcCtD
Nicardipine—Vertigo—Prednisolone—ankylosing spondylitis	0.000491	0.00469	CcSEcCtD
Nicardipine—Syncope—Prednisolone—ankylosing spondylitis	0.00049	0.00469	CcSEcCtD
Nicardipine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00048	0.00459	CcSEcCtD
Nicardipine—Hypertension—Prednisolone—ankylosing spondylitis	0.000471	0.00451	CcSEcCtD
Nicardipine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000466	0.00446	CcSEcCtD
Nicardipine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000465	0.00445	CcSEcCtD
Nicardipine—Discomfort—Prednisolone—ankylosing spondylitis	0.000459	0.0044	CcSEcCtD
Nicardipine—Malaise—Triamcinolone—ankylosing spondylitis	0.000453	0.00433	CcSEcCtD
Nicardipine—Malaise—Methylprednisolone—ankylosing spondylitis	0.000452	0.00432	CcSEcCtD
Nicardipine—Vertigo—Triamcinolone—ankylosing spondylitis	0.000451	0.00432	CcSEcCtD
Nicardipine—Syncope—Triamcinolone—ankylosing spondylitis	0.00045	0.00431	CcSEcCtD
Nicardipine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00045	0.00431	CcSEcCtD
Nicardipine—Syncope—Methylprednisolone—ankylosing spondylitis	0.000449	0.0043	CcSEcCtD
Nicardipine—Oedema—Prednisolone—ankylosing spondylitis	0.000446	0.00426	CcSEcCtD
Nicardipine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000441	0.00422	CcSEcCtD
Nicardipine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00044	0.00421	CcSEcCtD
Nicardipine—Shock—Prednisolone—ankylosing spondylitis	0.000438	0.0042	CcSEcCtD
Nicardipine—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000438	0.00419	CcSEcCtD
Nicardipine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000435	0.00416	CcSEcCtD
Nicardipine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000434	0.00415	CcSEcCtD
Nicardipine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000433	0.00414	CcSEcCtD
Nicardipine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000431	0.00412	CcSEcCtD
Nicardipine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000428	0.00409	CcSEcCtD
Nicardipine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000427	0.00408	CcSEcCtD
Nicardipine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000427	0.00408	CcSEcCtD
Nicardipine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000425	0.00407	CcSEcCtD
Nicardipine—Flushing—Prednisone—ankylosing spondylitis	0.000423	0.00405	CcSEcCtD
Nicardipine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000423	0.00405	CcSEcCtD
Nicardipine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000423	0.00405	CcSEcCtD
Nicardipine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000422	0.00404	CcSEcCtD
Nicardipine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000421	0.00403	CcSEcCtD
Nicardipine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000418	0.004	CcSEcCtD
Nicardipine—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000412	0.00395	CcSEcCtD
Nicardipine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000412	0.00395	CcSEcCtD
Nicardipine—Malaise—Betamethasone—ankylosing spondylitis	0.000411	0.00393	CcSEcCtD
Nicardipine—Malaise—Dexamethasone—ankylosing spondylitis	0.000411	0.00393	CcSEcCtD
Nicardipine—Oedema—Triamcinolone—ankylosing spondylitis	0.00041	0.00392	CcSEcCtD
Nicardipine—Vertigo—Betamethasone—ankylosing spondylitis	0.000409	0.00392	CcSEcCtD
Nicardipine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000409	0.00392	CcSEcCtD
Nicardipine—Syncope—Dexamethasone—ankylosing spondylitis	0.000409	0.00391	CcSEcCtD
Nicardipine—Syncope—Betamethasone—ankylosing spondylitis	0.000409	0.00391	CcSEcCtD
Nicardipine—Infection—Triamcinolone—ankylosing spondylitis	0.000407	0.0039	CcSEcCtD
Nicardipine—Sweating—Methotrexate—ankylosing spondylitis	0.000407	0.00389	CcSEcCtD
Nicardipine—Infection—Methylprednisolone—ankylosing spondylitis	0.000406	0.00389	CcSEcCtD
Nicardipine—Haematuria—Methotrexate—ankylosing spondylitis	0.000405	0.00387	CcSEcCtD
Nicardipine—Shock—Triamcinolone—ankylosing spondylitis	0.000403	0.00386	CcSEcCtD
Nicardipine—Insomnia—Prednisolone—ankylosing spondylitis	0.000403	0.00386	CcSEcCtD
Nicardipine—Shock—Methylprednisolone—ankylosing spondylitis	0.000402	0.00385	CcSEcCtD
Nicardipine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.0004	0.00383	CcSEcCtD
Nicardipine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.0004	0.00383	CcSEcCtD
Nicardipine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.0004	0.00383	CcSEcCtD
Nicardipine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.0004	0.00383	CcSEcCtD
Nicardipine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000399	0.00382	CcSEcCtD
Nicardipine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000396	0.00379	CcSEcCtD
Nicardipine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000395	0.00378	CcSEcCtD
Nicardipine—Hypertension—Betamethasone—ankylosing spondylitis	0.000393	0.00376	CcSEcCtD
Nicardipine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000393	0.00376	CcSEcCtD
Nicardipine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000388	0.00371	CcSEcCtD
Nicardipine—Myalgia—Betamethasone—ankylosing spondylitis	0.000388	0.00371	CcSEcCtD
Nicardipine—Anxiety—Betamethasone—ankylosing spondylitis	0.000387	0.0037	CcSEcCtD
Nicardipine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000387	0.0037	CcSEcCtD
Nicardipine—Discomfort—Betamethasone—ankylosing spondylitis	0.000383	0.00367	CcSEcCtD
Nicardipine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000383	0.00367	CcSEcCtD
Nicardipine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000382	0.00366	CcSEcCtD
Nicardipine—Pain—Prednisolone—ankylosing spondylitis	0.000381	0.00365	CcSEcCtD
Nicardipine—Vision blurred—Prednisone—ankylosing spondylitis	0.000374	0.00358	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000373	0.00357	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000373	0.00356	CcSEcCtD
Nicardipine—Oedema—Dexamethasone—ankylosing spondylitis	0.000372	0.00356	CcSEcCtD
Nicardipine—Oedema—Betamethasone—ankylosing spondylitis	0.000372	0.00356	CcSEcCtD
Nicardipine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000371	0.00355	CcSEcCtD
Nicardipine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00037	0.00354	CcSEcCtD
Nicardipine—Infection—Dexamethasone—ankylosing spondylitis	0.000369	0.00353	CcSEcCtD
Nicardipine—Infection—Betamethasone—ankylosing spondylitis	0.000369	0.00353	CcSEcCtD
Nicardipine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000368	0.00352	CcSEcCtD
Nicardipine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000368	0.00352	CcSEcCtD
Nicardipine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000367	0.00351	CcSEcCtD
Nicardipine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000367	0.00351	CcSEcCtD
Nicardipine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000367	0.00351	CcSEcCtD
Nicardipine—Shock—Dexamethasone—ankylosing spondylitis	0.000366	0.0035	CcSEcCtD
Nicardipine—Shock—Betamethasone—ankylosing spondylitis	0.000366	0.0035	CcSEcCtD
Nicardipine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000365	0.0035	CcSEcCtD
Nicardipine—Agitation—Prednisone—ankylosing spondylitis	0.000365	0.00349	CcSEcCtD
Nicardipine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000364	0.00348	CcSEcCtD
Nicardipine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000364	0.00348	CcSEcCtD
Nicardipine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000363	0.00347	CcSEcCtD
Nicardipine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000363	0.00347	CcSEcCtD
Nicardipine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000361	0.00345	CcSEcCtD
Nicardipine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00036	0.00344	CcSEcCtD
Nicardipine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000359	0.00344	CcSEcCtD
Nicardipine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000359	0.00344	CcSEcCtD
Nicardipine—Malaise—Prednisone—ankylosing spondylitis	0.000358	0.00342	CcSEcCtD
Nicardipine—Vertigo—Prednisone—ankylosing spondylitis	0.000356	0.00341	CcSEcCtD
Nicardipine—Syncope—Prednisone—ankylosing spondylitis	0.000356	0.0034	CcSEcCtD
Nicardipine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000355	0.0034	CcSEcCtD
Nicardipine—Pain—Triamcinolone—ankylosing spondylitis	0.00035	0.00335	CcSEcCtD
Nicardipine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000349	0.00334	CcSEcCtD
Nicardipine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000347	0.00332	CcSEcCtD
Nicardipine—Hypotension—Betamethasone—ankylosing spondylitis	0.000347	0.00332	CcSEcCtD
Nicardipine—Hypertension—Prednisone—ankylosing spondylitis	0.000343	0.00328	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000339	0.00324	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000339	0.00324	CcSEcCtD
Nicardipine—Arthralgia—Prednisone—ankylosing spondylitis	0.000338	0.00323	CcSEcCtD
Nicardipine—Myalgia—Prednisone—ankylosing spondylitis	0.000338	0.00323	CcSEcCtD
Nicardipine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000338	0.00323	CcSEcCtD
Nicardipine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000337	0.00322	CcSEcCtD
Nicardipine—Anxiety—Prednisone—ankylosing spondylitis	0.000337	0.00322	CcSEcCtD
Nicardipine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000336	0.00322	CcSEcCtD
Nicardipine—Insomnia—Betamethasone—ankylosing spondylitis	0.000336	0.00322	CcSEcCtD
Nicardipine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000334	0.0032	CcSEcCtD
Nicardipine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000334	0.0032	CcSEcCtD
Nicardipine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000334	0.0032	CcSEcCtD
Nicardipine—Discomfort—Prednisone—ankylosing spondylitis	0.000334	0.00319	CcSEcCtD
Nicardipine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000328	0.00314	CcSEcCtD
Nicardipine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000327	0.00313	CcSEcCtD
Nicardipine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000327	0.00313	CcSEcCtD
Nicardipine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000324	0.0031	CcSEcCtD
Nicardipine—Oedema—Prednisone—ankylosing spondylitis	0.000324	0.0031	CcSEcCtD
Nicardipine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000323	0.00309	CcSEcCtD
Nicardipine—Infection—Prednisone—ankylosing spondylitis	0.000322	0.00308	CcSEcCtD
Nicardipine—Shock—Prednisone—ankylosing spondylitis	0.000319	0.00305	CcSEcCtD
Nicardipine—Pain—Dexamethasone—ankylosing spondylitis	0.000318	0.00304	CcSEcCtD
Nicardipine—Pain—Betamethasone—ankylosing spondylitis	0.000318	0.00304	CcSEcCtD
Nicardipine—Tachycardia—Prednisone—ankylosing spondylitis	0.000316	0.00302	CcSEcCtD
Nicardipine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000313	0.003	CcSEcCtD
Nicardipine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000313	0.00299	CcSEcCtD
Nicardipine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000308	0.00294	CcSEcCtD
Nicardipine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000306	0.00293	CcSEcCtD
Nicardipine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000306	0.00293	CcSEcCtD
Nicardipine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000304	0.00291	CcSEcCtD
Nicardipine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000304	0.00291	CcSEcCtD
Nicardipine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000302	0.00289	CcSEcCtD
Nicardipine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000301	0.00288	CcSEcCtD
Nicardipine—Malaise—Methotrexate—ankylosing spondylitis	0.000299	0.00286	CcSEcCtD
Nicardipine—Vertigo—Methotrexate—ankylosing spondylitis	0.000298	0.00285	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000295	0.00282	CcSEcCtD
Nicardipine—Dizziness—Prednisolone—ankylosing spondylitis	0.000295	0.00282	CcSEcCtD
Nicardipine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000294	0.00281	CcSEcCtD
Nicardipine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000294	0.00281	CcSEcCtD
Nicardipine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000294	0.00281	CcSEcCtD
Nicardipine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000294	0.00281	CcSEcCtD
Nicardipine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000294	0.00281	CcSEcCtD
Nicardipine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000293	0.00281	CcSEcCtD
Nicardipine—Insomnia—Prednisone—ankylosing spondylitis	0.000293	0.0028	CcSEcCtD
Nicardipine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000291	0.00278	CcSEcCtD
Nicardipine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000285	0.00273	CcSEcCtD
Nicardipine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000282	0.0027	CcSEcCtD
Nicardipine—Chest pain—Methotrexate—ankylosing spondylitis	0.000282	0.0027	CcSEcCtD
Nicardipine—Myalgia—Methotrexate—ankylosing spondylitis	0.000282	0.0027	CcSEcCtD
Nicardipine—Rash—Prednisolone—ankylosing spondylitis	0.000281	0.00269	CcSEcCtD
Nicardipine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000281	0.00269	CcSEcCtD
Nicardipine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00028	0.00268	CcSEcCtD
Nicardipine—Headache—Prednisolone—ankylosing spondylitis	0.000279	0.00267	CcSEcCtD
Nicardipine—Discomfort—Methotrexate—ankylosing spondylitis	0.000279	0.00267	CcSEcCtD
Nicardipine—Constipation—Prednisone—ankylosing spondylitis	0.000277	0.00265	CcSEcCtD
Nicardipine—Confusional state—Methotrexate—ankylosing spondylitis	0.000273	0.00261	CcSEcCtD
Nicardipine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000271	0.00259	CcSEcCtD
Nicardipine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00027	0.00259	CcSEcCtD
Nicardipine—Infection—Methotrexate—ankylosing spondylitis	0.000269	0.00257	CcSEcCtD
Nicardipine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000267	0.00255	CcSEcCtD
Nicardipine—Asthenia—Betamethasone—ankylosing spondylitis	0.000267	0.00255	CcSEcCtD
Nicardipine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000267	0.00255	CcSEcCtD
Nicardipine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000265	0.00254	CcSEcCtD
Nicardipine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000265	0.00253	CcSEcCtD
Nicardipine—Nausea—Prednisolone—ankylosing spondylitis	0.000265	0.00253	CcSEcCtD
Nicardipine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000262	0.0025	CcSEcCtD
Nicardipine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000261	0.00249	CcSEcCtD
Nicardipine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00026	0.00249	CcSEcCtD
Nicardipine—Rash—Triamcinolone—ankylosing spondylitis	0.000258	0.00247	CcSEcCtD
Nicardipine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000258	0.00247	CcSEcCtD
Nicardipine—Rash—Methylprednisolone—ankylosing spondylitis	0.000258	0.00247	CcSEcCtD
Nicardipine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000258	0.00246	CcSEcCtD
Nicardipine—Headache—Triamcinolone—ankylosing spondylitis	0.000257	0.00246	CcSEcCtD
Nicardipine—Headache—Methylprednisolone—ankylosing spondylitis	0.000256	0.00245	CcSEcCtD
Nicardipine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000256	0.00245	CcSEcCtD
Nicardipine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000256	0.00245	CcSEcCtD
Nicardipine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000254	0.00243	CcSEcCtD
Nicardipine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000254	0.00243	CcSEcCtD
Nicardipine—Hypotension—Methotrexate—ankylosing spondylitis	0.000253	0.00242	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000247	0.00236	CcSEcCtD
Nicardipine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000246	0.00235	CcSEcCtD
Nicardipine—Dizziness—Betamethasone—ankylosing spondylitis	0.000246	0.00235	CcSEcCtD
Nicardipine—Insomnia—Methotrexate—ankylosing spondylitis	0.000245	0.00234	CcSEcCtD
Nicardipine—Nausea—Triamcinolone—ankylosing spondylitis	0.000243	0.00233	CcSEcCtD
Nicardipine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000243	0.00233	CcSEcCtD
Nicardipine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000243	0.00232	CcSEcCtD
Nicardipine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000241	0.00231	CcSEcCtD
Nicardipine—Somnolence—Methotrexate—ankylosing spondylitis	0.000241	0.0023	CcSEcCtD
Nicardipine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000239	0.00228	CcSEcCtD
Nicardipine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000238	0.00228	CcSEcCtD
Nicardipine—Vomiting—Betamethasone—ankylosing spondylitis	0.000236	0.00226	CcSEcCtD
Nicardipine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000236	0.00226	CcSEcCtD
Nicardipine—Rash—Betamethasone—ankylosing spondylitis	0.000234	0.00224	CcSEcCtD
Nicardipine—Rash—Dexamethasone—ankylosing spondylitis	0.000234	0.00224	CcSEcCtD
Nicardipine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000234	0.00224	CcSEcCtD
Nicardipine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000234	0.00224	CcSEcCtD
Nicardipine—Headache—Dexamethasone—ankylosing spondylitis	0.000233	0.00223	CcSEcCtD
Nicardipine—Headache—Betamethasone—ankylosing spondylitis	0.000233	0.00223	CcSEcCtD
Nicardipine—Asthenia—Prednisone—ankylosing spondylitis	0.000232	0.00222	CcSEcCtD
Nicardipine—Pain—Methotrexate—ankylosing spondylitis	0.000231	0.00221	CcSEcCtD
Nicardipine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000223	0.00213	CcSEcCtD
Nicardipine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000222	0.00212	CcSEcCtD
Nicardipine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000221	0.00212	CcSEcCtD
Nicardipine—Nausea—Betamethasone—ankylosing spondylitis	0.000221	0.00211	CcSEcCtD
Nicardipine—Nausea—Dexamethasone—ankylosing spondylitis	0.000221	0.00211	CcSEcCtD
Nicardipine—Dizziness—Prednisone—ankylosing spondylitis	0.000214	0.00205	CcSEcCtD
Nicardipine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000214	0.00205	CcSEcCtD
Nicardipine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000214	0.00205	CcSEcCtD
Nicardipine—Vomiting—Prednisone—ankylosing spondylitis	0.000206	0.00197	CcSEcCtD
Nicardipine—Rash—Prednisone—ankylosing spondylitis	0.000204	0.00195	CcSEcCtD
Nicardipine—Dermatitis—Prednisone—ankylosing spondylitis	0.000204	0.00195	CcSEcCtD
Nicardipine—Headache—Prednisone—ankylosing spondylitis	0.000203	0.00194	CcSEcCtD
Nicardipine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000199	0.00191	CcSEcCtD
Nicardipine—Asthenia—Methotrexate—ankylosing spondylitis	0.000194	0.00186	CcSEcCtD
Nicardipine—Nausea—Prednisone—ankylosing spondylitis	0.000192	0.00184	CcSEcCtD
Nicardipine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000185	0.00177	CcSEcCtD
Nicardipine—CALM2—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000183	0.00309	CbGpPWpGaD
Nicardipine—CALM1—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000183	0.00309	CbGpPWpGaD
Nicardipine—CALM2—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.000183	0.00309	CbGpPWpGaD
Nicardipine—CALM1—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.000183	0.00309	CbGpPWpGaD
Nicardipine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000182	0.00308	CbGpPWpGaD
Nicardipine—Dizziness—Methotrexate—ankylosing spondylitis	0.000179	0.00171	CcSEcCtD
Nicardipine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000178	0.00301	CbGpPWpGaD
Nicardipine—ADRA1B—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000173	0.00291	CbGpPWpGaD
Nicardipine—Vomiting—Methotrexate—ankylosing spondylitis	0.000172	0.00165	CcSEcCtD
Nicardipine—PDE1B—Immune System—CARD9—ankylosing spondylitis	0.000172	0.0029	CbGpPWpGaD
Nicardipine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000171	0.00289	CbGpPWpGaD
Nicardipine—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	0.000171	0.00289	CbGpPWpGaD
Nicardipine—Rash—Methotrexate—ankylosing spondylitis	0.000171	0.00163	CcSEcCtD
Nicardipine—Dermatitis—Methotrexate—ankylosing spondylitis	0.00017	0.00163	CcSEcCtD
Nicardipine—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	0.00017	0.00287	CbGpPWpGaD
Nicardipine—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	0.00017	0.00287	CbGpPWpGaD
Nicardipine—Headache—Methotrexate—ankylosing spondylitis	0.00017	0.00162	CcSEcCtD
Nicardipine—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000162	0.00274	CbGpPWpGaD
Nicardipine—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	0.000162	0.00273	CbGpPWpGaD
Nicardipine—Nausea—Methotrexate—ankylosing spondylitis	0.000161	0.00154	CcSEcCtD
Nicardipine—CHRM1—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000156	0.00263	CbGpPWpGaD
Nicardipine—CHRM3—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000155	0.00262	CbGpPWpGaD
Nicardipine—CHRM2—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.000155	0.00261	CbGpPWpGaD
Nicardipine—CHRM2—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.000154	0.0026	CbGpPWpGaD
Nicardipine—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000154	0.0026	CbGpPWpGaD
Nicardipine—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000153	0.00259	CbGpPWpGaD
Nicardipine—CHRM4—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000151	0.00254	CbGpPWpGaD
Nicardipine—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	0.00015	0.00253	CbGpPWpGaD
Nicardipine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000148	0.0025	CbGpPWpGaD
Nicardipine—PDE1A—Disease—B3GNT2—ankylosing spondylitis	0.000148	0.00249	CbGpPWpGaD
Nicardipine—CHRM5—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000144	0.00244	CbGpPWpGaD
Nicardipine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000142	0.0024	CbGpPWpGaD
Nicardipine—ADRA1D—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000136	0.00229	CbGpPWpGaD
Nicardipine—PDE1B—Disease—B3GNT2—ankylosing spondylitis	0.000135	0.00228	CbGpPWpGaD
Nicardipine—CALM3—B Cell Activation—CD79A—ankylosing spondylitis	0.000133	0.00225	CbGpPWpGaD
Nicardipine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000133	0.00225	CbGpPWpGaD
Nicardipine—CHRM3—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000133	0.00225	CbGpPWpGaD
Nicardipine—PDE1A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000132	0.00223	CbGpPWpGaD
Nicardipine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000132	0.00222	CbGpPWpGaD
Nicardipine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000131	0.00222	CbGpPWpGaD
Nicardipine—CALM3—Immune System—KIR3DL1—ankylosing spondylitis	0.00013	0.00219	CbGpPWpGaD
Nicardipine—CALM1—B Cell Activation—CD79A—ankylosing spondylitis	0.000129	0.00218	CbGpPWpGaD
Nicardipine—CALM2—B Cell Activation—CD79A—ankylosing spondylitis	0.000129	0.00218	CbGpPWpGaD
Nicardipine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000128	0.00217	CbGpPWpGaD
Nicardipine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000128	0.00216	CbGpPWpGaD
Nicardipine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000126	0.00213	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KIR3DL1—ankylosing spondylitis	0.000126	0.00212	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KIR3DL1—ankylosing spondylitis	0.000126	0.00212	CbGpPWpGaD
Nicardipine—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000123	0.00208	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000123	0.00207	CbGpPWpGaD
Nicardipine—CACNB2—Metabolism—B3GNT2—ankylosing spondylitis	0.000122	0.00206	CbGpPWpGaD
Nicardipine—PDE1B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000121	0.00204	CbGpPWpGaD
Nicardipine—PDE1A—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00012	0.00203	CbGpPWpGaD
Nicardipine—PDE1A—Innate Immune System—HLA-B—ankylosing spondylitis	0.00012	0.00202	CbGpPWpGaD
Nicardipine—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000119	0.00201	CbGpPWpGaD
Nicardipine—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000119	0.00201	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000119	0.00201	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000119	0.00201	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—HLA-C—ankylosing spondylitis	0.000118	0.00199	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—CARD9—ankylosing spondylitis	0.000117	0.00198	CbGpPWpGaD
Nicardipine—CACNA1D—Metabolism—B3GNT2—ankylosing spondylitis	0.000116	0.00195	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—CARD9—ankylosing spondylitis	0.000113	0.00191	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—CARD9—ankylosing spondylitis	0.000113	0.00191	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000113	0.0019	CbGpPWpGaD
Nicardipine—CALM3—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000112	0.00189	CbGpPWpGaD
Nicardipine—CALM2—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.00011	0.00186	CbGpPWpGaD
Nicardipine—CALM1—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.00011	0.00186	CbGpPWpGaD
Nicardipine—PDE1B—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00011	0.00185	CbGpPWpGaD
Nicardipine—PDE1B—Innate Immune System—HLA-B—ankylosing spondylitis	0.00011	0.00185	CbGpPWpGaD
Nicardipine—CALM2—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000108	0.00183	CbGpPWpGaD
Nicardipine—CALM1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000108	0.00183	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—HLA-C—ankylosing spondylitis	0.000108	0.00182	CbGpPWpGaD
Nicardipine—PDE1A—Innate Immune System—CRP—ankylosing spondylitis	0.000106	0.00179	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—IL1RN—ankylosing spondylitis	0.000103	0.00173	CbGpPWpGaD
Nicardipine—CACNA1C—Metabolism—B3GNT2—ankylosing spondylitis	0.000102	0.00172	CbGpPWpGaD
Nicardipine—CHRM1—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000102	0.00172	CbGpPWpGaD
Nicardipine—PDE1A—Innate Immune System—TLR4—ankylosing spondylitis	0.000102	0.00172	CbGpPWpGaD
Nicardipine—CHRM3—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000101	0.00171	CbGpPWpGaD
Nicardipine—CHRM2—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.0001	0.00169	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.0001	0.00169	CbGpPWpGaD
Nicardipine—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	9.85e-05	0.00166	CbGpPWpGaD
Nicardipine—PDE1B—Innate Immune System—CRP—ankylosing spondylitis	9.69e-05	0.00164	CbGpPWpGaD
Nicardipine—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	9.53e-05	0.00161	CbGpPWpGaD
Nicardipine—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	9.53e-05	0.00161	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—IL1RN—ankylosing spondylitis	9.38e-05	0.00158	CbGpPWpGaD
Nicardipine—PDE1B—Innate Immune System—TLR4—ankylosing spondylitis	9.29e-05	0.00157	CbGpPWpGaD
Nicardipine—CALM3—Disease—ANTXR2—ankylosing spondylitis	9.08e-05	0.00153	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—CD79A—ankylosing spondylitis	9e-05	0.00152	CbGpPWpGaD
Nicardipine—CALM1—Disease—ANTXR2—ankylosing spondylitis	8.78e-05	0.00148	CbGpPWpGaD
Nicardipine—CALM2—Disease—ANTXR2—ankylosing spondylitis	8.78e-05	0.00148	CbGpPWpGaD
Nicardipine—PDE1A—Signaling by GPCR—MMP3—ankylosing spondylitis	8.54e-05	0.00144	CbGpPWpGaD
Nicardipine—CALM3—Alzheimers Disease—TNF—ankylosing spondylitis	8.53e-05	0.00144	CbGpPWpGaD
Nicardipine—CHRM4—GPCR downstream signaling—PTGER4—ankylosing spondylitis	8.51e-05	0.00144	CbGpPWpGaD
Nicardipine—CALM2—Alzheimers Disease—TNF—ankylosing spondylitis	8.25e-05	0.00139	CbGpPWpGaD
Nicardipine—CALM1—Alzheimers Disease—TNF—ankylosing spondylitis	8.25e-05	0.00139	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—CD79A—ankylosing spondylitis	8.23e-05	0.00139	CbGpPWpGaD
Nicardipine—CHRM5—GPCR downstream signaling—PTGER4—ankylosing spondylitis	8.15e-05	0.00138	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL1R2—ankylosing spondylitis	7.86e-05	0.00133	CbGpPWpGaD
Nicardipine—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	7.86e-05	0.00133	CbGpPWpGaD
Nicardipine—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	7.86e-05	0.00133	CbGpPWpGaD
Nicardipine—PDE1B—Signaling by GPCR—MMP3—ankylosing spondylitis	7.81e-05	0.00132	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.73e-05	0.00131	CbGpPWpGaD
Nicardipine—ADRA1D—GPCR downstream signaling—PTGER4—ankylosing spondylitis	7.66e-05	0.00129	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL1R2—ankylosing spondylitis	7.6e-05	0.00128	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL1R2—ankylosing spondylitis	7.6e-05	0.00128	CbGpPWpGaD
Nicardipine—CALM3—Immune System—ERAP1—ankylosing spondylitis	7.45e-05	0.00126	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.4e-05	0.00125	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—IL1A—ankylosing spondylitis	7.38e-05	0.00125	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—HLA-C—ankylosing spondylitis	7.35e-05	0.00124	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—CD40LG—ankylosing spondylitis	7.34e-05	0.00124	CbGpPWpGaD
Nicardipine—CALM2—Immune System—ERAP1—ankylosing spondylitis	7.21e-05	0.00122	CbGpPWpGaD
Nicardipine—CALM1—Immune System—ERAP1—ankylosing spondylitis	7.21e-05	0.00122	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—HLA-C—ankylosing spondylitis	7.11e-05	0.0012	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—HLA-C—ankylosing spondylitis	7.11e-05	0.0012	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—PTGER4—ankylosing spondylitis	7.09e-05	0.0012	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—HLA-C—ankylosing spondylitis	7.06e-05	0.00119	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—HLA-B—ankylosing spondylitis	6.98e-05	0.00118	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—PTGER4—ankylosing spondylitis	6.96e-05	0.00118	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—HLA-C—ankylosing spondylitis	6.83e-05	0.00115	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—HLA-C—ankylosing spondylitis	6.83e-05	0.00115	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CARD9—ankylosing spondylitis	6.82e-05	0.00115	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—IL1A—ankylosing spondylitis	6.75e-05	0.00114	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—CD40LG—ankylosing spondylitis	6.71e-05	0.00113	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CARD9—ankylosing spondylitis	6.59e-05	0.00111	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CARD9—ankylosing spondylitis	6.59e-05	0.00111	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—PTGER4—ankylosing spondylitis	6.48e-05	0.00109	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—HLA-A—ankylosing spondylitis	6.47e-05	0.00109	CbGpPWpGaD
Nicardipine—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	6.47e-05	0.00109	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—HLA-B—ankylosing spondylitis	6.38e-05	0.00108	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR downstream signaling—PTGER4—ankylosing spondylitis	6.36e-05	0.00107	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—CRP—ankylosing spondylitis	6.17e-05	0.00104	CbGpPWpGaD
Nicardipine—PDE1A—Disease—HLA-A—ankylosing spondylitis	5.97e-05	0.00101	CbGpPWpGaD
Nicardipine—PDE1A—Immune System—TLR4—ankylosing spondylitis	5.91e-05	0.000999	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—HLA-A—ankylosing spondylitis	5.91e-05	0.000999	CbGpPWpGaD
Nicardipine—CHRM2—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	5.86e-05	0.000989	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.78e-05	0.000976	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	5.74e-05	0.000969	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—PTGER4—ankylosing spondylitis	5.72e-05	0.000966	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—PTGER4—ankylosing spondylitis	5.67e-05	0.000957	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—PTGER4—ankylosing spondylitis	5.65e-05	0.000954	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—CRP—ankylosing spondylitis	5.64e-05	0.000953	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—MMP3—ankylosing spondylitis	5.5e-05	0.00093	CbGpPWpGaD
Nicardipine—PDE1B—Disease—HLA-A—ankylosing spondylitis	5.46e-05	0.000922	CbGpPWpGaD
Nicardipine—PDE1B—Immune System—TLR4—ankylosing spondylitis	5.41e-05	0.000914	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—CD79A—ankylosing spondylitis	5.38e-05	0.000909	CbGpPWpGaD
Nicardipine—CACNB2—Developmental Biology—TNF—ankylosing spondylitis	5.37e-05	0.000907	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—B3GNT2—ankylosing spondylitis	5.35e-05	0.000904	CbGpPWpGaD
Nicardipine—CALM3—Disease—B3GNT2—ankylosing spondylitis	5.35e-05	0.000904	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—MMP3—ankylosing spondylitis	5.27e-05	0.00089	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.21e-05	0.00088	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—CD79A—ankylosing spondylitis	5.21e-05	0.000879	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—CD79A—ankylosing spondylitis	5.21e-05	0.000879	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.2e-05	0.000878	CbGpPWpGaD
Nicardipine—CALM2—Disease—B3GNT2—ankylosing spondylitis	5.18e-05	0.000874	CbGpPWpGaD
Nicardipine—CALM1—Disease—B3GNT2—ankylosing spondylitis	5.18e-05	0.000874	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.15e-05	0.000869	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—PTGER4—ankylosing spondylitis	5.13e-05	0.000867	CbGpPWpGaD
Nicardipine—CACNA1D—Developmental Biology—TNF—ankylosing spondylitis	5.08e-05	0.000859	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—MMP3—ankylosing spondylitis	5.05e-05	0.000852	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—MMP3—ankylosing spondylitis	4.96e-05	0.000837	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—MMP3—ankylosing spondylitis	4.61e-05	0.000779	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—B3GNT2—ankylosing spondylitis	4.6e-05	0.000778	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—PTGER4—ankylosing spondylitis	4.57e-05	0.000771	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—B3GNT2—ankylosing spondylitis	4.51e-05	0.000762	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—B3GNT2—ankylosing spondylitis	4.5e-05	0.00076	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—B3GNT2—ankylosing spondylitis	4.48e-05	0.000757	CbGpPWpGaD
Nicardipine—CACNA1C—Developmental Biology—TNF—ankylosing spondylitis	4.47e-05	0.000754	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—CD40LG—ankylosing spondylitis	4.39e-05	0.000741	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—PTGER4—ankylosing spondylitis	4.37e-05	0.000739	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—PTGER4—ankylosing spondylitis	4.35e-05	0.000735	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—HLA-B—ankylosing spondylitis	4.35e-05	0.000734	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—B3GNT2—ankylosing spondylitis	4.33e-05	0.000732	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—B3GNT2—ankylosing spondylitis	4.33e-05	0.000732	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HLA-C—ankylosing spondylitis	4.28e-05	0.000723	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—CD40LG—ankylosing spondylitis	4.24e-05	0.000717	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—CD40LG—ankylosing spondylitis	4.24e-05	0.000717	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—PTGER4—ankylosing spondylitis	4.21e-05	0.000711	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—PTGER4—ankylosing spondylitis	4.21e-05	0.000711	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—HLA-B—ankylosing spondylitis	4.2e-05	0.00071	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—HLA-B—ankylosing spondylitis	4.2e-05	0.00071	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—HLA-B—ankylosing spondylitis	4.17e-05	0.000705	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HLA-C—ankylosing spondylitis	4.14e-05	0.000699	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HLA-C—ankylosing spondylitis	4.14e-05	0.000699	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—MMP3—ankylosing spondylitis	4.11e-05	0.000695	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—PTGER4—ankylosing spondylitis	4.11e-05	0.000694	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—HLA-B—ankylosing spondylitis	4.04e-05	0.000682	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—HLA-B—ankylosing spondylitis	4.04e-05	0.000682	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—B3GNT2—ankylosing spondylitis	3.9e-05	0.000658	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—HLA-A—ankylosing spondylitis	3.87e-05	0.000653	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—CRP—ankylosing spondylitis	3.84e-05	0.000649	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—HLA-A—ankylosing spondylitis	3.74e-05	0.000632	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—HLA-A—ankylosing spondylitis	3.74e-05	0.000632	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL1RN—ankylosing spondylitis	3.72e-05	0.000628	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—CRP—ankylosing spondylitis	3.72e-05	0.000627	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—CRP—ankylosing spondylitis	3.72e-05	0.000627	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—MMP3—ankylosing spondylitis	3.71e-05	0.000627	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—MMP3—ankylosing spondylitis	3.7e-05	0.000625	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—TLR4—ankylosing spondylitis	3.68e-05	0.000622	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—MMP3—ankylosing spondylitis	3.66e-05	0.000619	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—MMP3—ankylosing spondylitis	3.65e-05	0.000617	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL1RN—ankylosing spondylitis	3.6e-05	0.000607	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL1RN—ankylosing spondylitis	3.6e-05	0.000607	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—TLR4—ankylosing spondylitis	3.56e-05	0.000602	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—TLR4—ankylosing spondylitis	3.56e-05	0.000602	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—B3GNT2—ankylosing spondylitis	3.48e-05	0.000588	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PTGER4—ankylosing spondylitis	3.41e-05	0.000576	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	3.4e-05	0.000574	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CD79A—ankylosing spondylitis	3.26e-05	0.000551	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—MMP3—ankylosing spondylitis	3.25e-05	0.000549	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—B3GNT2—ankylosing spondylitis	3.2e-05	0.00054	CbGpPWpGaD
Nicardipine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	3.19e-05	0.000539	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—B3GNT2—ankylosing spondylitis	3.17e-05	0.000536	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CD79A—ankylosing spondylitis	3.16e-05	0.000533	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CD79A—ankylosing spondylitis	3.16e-05	0.000533	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MMP3—ankylosing spondylitis	3.11e-05	0.000526	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—MMP3—ankylosing spondylitis	3.1e-05	0.000523	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PTGER4—ankylosing spondylitis	3.08e-05	0.00052	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PTGER4—ankylosing spondylitis	3.07e-05	0.000518	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PTGER4—ankylosing spondylitis	3.04e-05	0.000513	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PTGER4—ankylosing spondylitis	3.03e-05	0.000512	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—MMP3—ankylosing spondylitis	3e-05	0.000506	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—MMP3—ankylosing spondylitis	3e-05	0.000506	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MMP3—ankylosing spondylitis	2.93e-05	0.000494	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL1A—ankylosing spondylitis	2.68e-05	0.000452	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CD40LG—ankylosing spondylitis	2.66e-05	0.000449	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL1A—ankylosing spondylitis	2.59e-05	0.000437	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL1A—ankylosing spondylitis	2.59e-05	0.000437	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CD40LG—ankylosing spondylitis	2.57e-05	0.000435	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CD40LG—ankylosing spondylitis	2.57e-05	0.000435	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PTGER4—ankylosing spondylitis	2.57e-05	0.000434	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HLA-B—ankylosing spondylitis	2.53e-05	0.000427	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PTGER4—ankylosing spondylitis	2.49e-05	0.00042	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PTGER4—ankylosing spondylitis	2.49e-05	0.00042	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HLA-B—ankylosing spondylitis	2.45e-05	0.000413	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HLA-B—ankylosing spondylitis	2.45e-05	0.000413	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MMP3—ankylosing spondylitis	2.43e-05	0.00041	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HLA-A—ankylosing spondylitis	2.34e-05	0.000396	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HLA-A—ankylosing spondylitis	2.27e-05	0.000383	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HLA-A—ankylosing spondylitis	2.27e-05	0.000383	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CRP—ankylosing spondylitis	2.24e-05	0.000378	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MMP3—ankylosing spondylitis	2.19e-05	0.00037	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MMP3—ankylosing spondylitis	2.19e-05	0.000369	CbGpPWpGaD
Nicardipine—CALM3—Disease—HLA-A—ankylosing spondylitis	2.17e-05	0.000366	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MMP3—ankylosing spondylitis	2.16e-05	0.000366	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CRP—ankylosing spondylitis	2.16e-05	0.000365	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CRP—ankylosing spondylitis	2.16e-05	0.000365	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MMP3—ankylosing spondylitis	2.16e-05	0.000365	CbGpPWpGaD
Nicardipine—CALM3—Immune System—TLR4—ankylosing spondylitis	2.14e-05	0.000362	CbGpPWpGaD
Nicardipine—CALM2—Disease—HLA-A—ankylosing spondylitis	2.09e-05	0.000354	CbGpPWpGaD
Nicardipine—CALM1—Disease—HLA-A—ankylosing spondylitis	2.09e-05	0.000354	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	2.09e-05	0.000353	CbGpPWpGaD
Nicardipine—CALM2—Immune System—TLR4—ankylosing spondylitis	2.07e-05	0.00035	CbGpPWpGaD
Nicardipine—CALM1—Immune System—TLR4—ankylosing spondylitis	2.07e-05	0.00035	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP3—ankylosing spondylitis	1.83e-05	0.000309	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP3—ankylosing spondylitis	1.77e-05	0.000299	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP3—ankylosing spondylitis	1.77e-05	0.000299	CbGpPWpGaD
